Qingyuan Li
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 6
- Cancer, Hypoxia, and Metabolism 4
- Gastroenterology top 10%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
-
- Gastric Cancer Management and Outcomes 6
- Lung Cancer Diagnosis and Treatment 5
-
- Obstructive Sleep Apnea Research 4
- Partner nations
- ChinaSouth KoreaJapan
In The Last Decade
Qingyuan Li
54 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 484
- Gastroenterology 58
- Molecular Biology 696
- Oncology 175
- Pulmonary and Respiratory Medicine 208
Countries citing papers authored by Qingyuan Li
This map shows the geographic impact of Qingyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyuan Li more than expected).
Fields of papers citing papers by Qingyuan Li
This network shows the impact of papers produced by Qingyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyuan Li. The network helps show where Qingyuan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingyuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 26 | |
| 14 | 2021 | 28 | |
| 15 | 2021 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2020 | 81 | |
| 18 | 2019 | 83 | |
| 19 | 2019 | 88 | |
| 20 | 2014 | 38 |
About Qingyuan Li
Qingyuan Li is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Health Informatics, having authored 62 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers), Gastric Cancer Management and Outcomes (6 papers), Epigenetics and DNA Methylation (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), RNA modifications and cancer (5 papers), Obstructive Sleep Apnea Research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (484 citations), Gastroenterology (58 citations) and Molecular Biology (696 citations). Qingyuan Li has collaborated with scholars based in China, South Korea and Japan. Frequent co-authors include Side Liu, Qiuhua Lai, Yuxin Fang, Xinke Wang, Qun Yan, Chun-Cai Gu, Yue Zhang, Chengcheng He, Jianqun Cai and Juan He.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.